Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6802358

O=C(CCCN1CCN(C(=O)/C=C/c2ccccc2)CC1)c1ccc2c(c1)CCNCC2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 11/20 0.58
ACHE P22303 1/20 0.47
HTR1A P08908 3/20 0.45
DRD2 P14416 3/20 0.45
HTR2A P28223 3/20 0.45
HTR2C P28335 3/20 0.45
HTR7 P34969 3/20 0.45
DRD3 P35462 3/20 0.45
DRD4 P21917 1/20 0.45
POLB P06746 1/20 0.44
HTR2B P41595 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GPR183 P32249 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
HRH1 P35367 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6803305 0.87 MCHR1 (0.63) MCHR1ACHEHTR1ADRD2HTR2A
Trifluoroacetic Acid SCHEMBL6799476 0.85 MCHR1 (0.60) MCHR1ACHEHTR1ADRD2HTR2A
Trifluoroacetic Acid SCHEMBL6802111 0.84 MCHR1 (0.64) MCHR1ACHEHTR1ADRD2HTR2A
Trifluoroacetic Acid SCHEMBL6807608 0.82 MCHR1 (0.62) MCHR1ACHEHTR1ADRD2HTR2A
Trifluoroacetic Acid SCHEMBL5429449 0.81 LMNA (0.49) MCHR1ACHEMEN1KMT2AALDH1A1
Trifluoroacetic Acid SCHEMBL5429452 0.81 LMNA (0.49) MCHR1ACHEMEN1KMT2AALDH1A1
Trifluoroacetic Acid SCHEMBL6802930 0.81 DRD2 (0.62) MCHR1ACHEHTR1ADRD2HTR2A
Trifluoroacetic Acid SCHEMBL6803735 0.81 MCHR1 (0.55) MCHR1ACHEHTR1ADRD2HTR2A
Trifluoroacetic Acid SCHEMBL6796340 0.81 ACHE (0.60) MCHR1ACHEHTR1ADRD2HTR2A
Trifluoroacetic Acid SCHEMBL6807449 0.81 MCHR1 (0.60) MCHR1ACHEHTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063699-A1 Gpr14 antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-04-01 US disclosed
EP-1310490-A1 GPR14 ANTAGONIST Takeda Chemical Industries, Ltd. (JP) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063699-A1 Gpr14 antagonist GPR142, GPR139, GPR4 MCHR1 191/4885ACHE 4719/4885HTR1A 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.